Sharda Cropchem delivered double-digit revenue growth and margin expansion, led by strong performance in NAFTA and LATAM, despite European weather headwinds and volume de-growth.
Sharada Cropchem scheduled a board meeting for 30 Oct 2026 to consider its H1 FY27 unaudited financial results. No financial figures or decisions are reported in this advance intimation.
Sharda Cropchem Ltd held its 23rd AGM on August 14, 2026. Shareholders adopted financial statements and approved a final dividend of Rs. 9.00 per share.
Sharda Cropchem reported Q1 FY27 revenue growth of 9% YoY to Rs 1,074 crores. EBITDA grew 25% to Rs 178 crores with margins expanding to 16.6% despite FX headwinds.
Sharda Cropchem reported Q1 FY27 revenue of ₹1,074 Cr (+9% YoY) and EBITDA of ₹178 Cr (+25% YoY). The company continues to leverage its asset-light, IP-led registration model.
Sharda Cropchem Limited will hold a board meeting on July 29, 2026, to consider unaudited standalone and consolidated financial results for the quarter ending June 2026.
Sharda Cropchem submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and operational highlights for the period.
Sharda Cropchem submitted its FY 2025-26 Annual Report. The company scheduled its 23rd AGM for August 14, 2026, and fixed August 7 as the dividend record date.
Sharda Cropchem will hold its 23rd AGM on August 14, 2026, via video conferencing. The company fixed August 7, 2026, as the record date for final dividend.
Sharda Cropchem submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no major non-compliances noted.
Sharda Cropchem recommended a final dividend of Rs. 9.00 per equity share for FY 2025-26. The payout remains subject to shareholder approval at the AGM.
Sharda Cropchem delivered strong FY26 results with a 22% revenue increase and 124% PAT growth. The company maintains an asset-light model focused on product registrations and global distribution across 80+ countries.
Sharda Cropchem recommended a final dividend of ₹9 per equity share for 2026. This distribution rewards shareholders following the board's approval on May 13.
Sharda Cropchem reported 22% revenue growth to ₹5,268 Crore for FY26. PAT more than doubled to ₹681 Crore, driven by strong volumes and improved product mix.
Sharda Cropchem approved its FY26 audited financial results and recommended a ₹9.00 per share final dividend. The board meeting concluded with an unmodified audit opinion.